Cognizant (NASDAQ: CTSH) director sells 2,000 shares via 10b5-1 plan
Rhea-AI Filing Summary
Cognizant Technology Solutions director Michael Patsalos-Fox reported selling 2,000 shares of Class A common stock on January 7, 2026. The sale was coded as an open market sale and was executed under a Rule 10b5-1 trading plan that he adopted on September 11, 2025. The weighted average sale price was $84.2301 per share, with individual trades occurring between $83.91 and $84.62.
Following this transaction, Patsalos-Fox beneficially owns 29,729 shares directly and 6,775 shares indirectly through PFOXFAMILY LLC. All membership interests of PFOXFAMILY LLC are held by a trust for the benefit of his children, with his spouse serving as co-trustee.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Cognizant (CTSH) report for Michael Patsalos-Fox?
Director Michael Patsalos-Fox reported an open market sale of 2,000 shares of Cognizant Technology Solutions Class A common stock on January 7, 2026.
At what price were the CTSH shares sold by director Michael Patsalos-Fox?
The reported weighted average sale price was $84.2301 per share, with individual trades between $83.91 and $84.62.
Was the Cognizant (CTSH) insider sale made under a Rule 10b5-1 plan?
Yes. The filing states the sales were executed under a Rule 10b5-1 trading plan adopted by Michael Patsalos-Fox on September 11, 2025.
How many CTSH shares does Michael Patsalos-Fox own after the reported sale?
After the sale, he beneficially owns 29,729 shares directly and 6,775 shares indirectly through PFOXFAMILY LLC.
What is PFOXFAMILY LLC in relation to the Cognizant (CTSH) insider holdings?
PFOXFAMILY LLC holds 6,775 shares indirectly reported by Patsalos-Fox. All membership interests are held by a trust for his children, and his spouse is co-trustee.
What role does Michael Patsalos-Fox have at Cognizant (CTSH)?
Michael Patsalos-Fox is reported as a director of Cognizant Technology Solutions Corporation.